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Sir,
Leukoencephalopathies in children are a heterogeneous group of disorders affecting the white matter of the 
brain, and often pose a major challenge to the treating physician for the appropriate aetiological diagnosis 
and management. Van der Knapp and others described a peculiar form of leukoenchalopathy affecting the 
basal ganglia and cerebellum in children with extensive hypomyelination; however, since that publication, few 
cases have been reported in the literature.1 The patients described had normal births and early development 
followed by an extrapyramidal movement disorder in the form of dystonia, spasticity, and ataxia, with 
global developmental regression. Magnetic resonance imaging (MRI) of the brain showed characteristic 
hypomyelination with atrophy of  basal ganglia and cerebellum; however, the thalamus and globus pallidus 
were spared. The molecular basis for the diagnosis has never been established for this disease.4 However, 
histopathologyhas been able to confirm extensive myelin loss in the aforementioned areas of the brain.2 
We report a two-year-old Nigerian boy with clinical and radiological features of hypomyelination, and mild 
atrophy of the basal ganglia and cerebellum.  
The boy was brought to our hospital by his parents due to abnormal movements of his trunk and limbs 
from 8 months of age. He was born full-term to non-consanguineous parents. He had a normal perinatal 
and postnatal history. The boy had been sent home two days after delivery and had had normal development 
until 8 months of age, when he had been  able to sit with support and could hold objects in his hands. 
However, his mother noticed that, when he was crying, the boy would develop stiffness in both legs, with 
more stiffness on his left side. After a few months, he lost the ability to sit as the stiffness increased in severity 
and progressed to involve all 4 limbs. He was unable to interact with his parents and had orofacial dyskinesia 
which interfered with feeding. He was seen by doctors and was started on anti-epileptic drugs with no 
benefit. When he presented to us, he was severely malnourished and bed-ridden, with extensive orolingual 
dyskinesia movements. There was dystonia of both axial and appendicular integuments with intermittent 
opisthotonos posturing. His cognitive skills were severely compromised and he could not communicate 
with his parents. A neurological examination revealed normal cranial nerve function, rigidity of all four 
limbs including the trunk, few choreiform movements of the extremities, and normal deep tendon reflexes 
and flexor plantar responses. There were no Kayser-Fleischer rings, and other systemic examinations were 
unremarkable. A routine biochemistry and metabolic work-up, including a leukocyte enzymes estimation, an 
evaluation of serum copper and ceruloplasmin levels, and a human immunodeficiency virus (HIV) screening 
were normal. An MRI brain study revealed severe cortical atrophy with hypomyelination and atrophy of the 
caudate and putamen nuclei as well as the cerebellum. [Figure 1] 
He was treated with carbiodopa+levodopa (sinemet) and benzodiazepine after discontinuing all anti-
epileptic drugs. In the initial weeks, he showed symptomatic improvement, but the symptoms recurred 
despite adequate dosages of the above medications. 
Our case clearly illustrates the importance of neuro-imaging in the diagnosis of hypomyelination with basal 
ganglia and cerebellar atrophy after ruling out other causes of dystonia with the  available diagnostic tools. 
Leukoencephalopathies have distinctive clinical and radiological findings, and aetiological confirmation could 
be established with an extensive molecular genetic work-up. This would help patients acquire appropriate 
genetic counselling and possibly a potential curative treatment. However, in reality, more than half of these 
disorders remain undiagnosed because of the lack of availability of neuroimaging tools and, in such conditions, 
specific MRI findings could establish the correct diagnosis. Recently described leukoencephalopathies, such 
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as vanishing white matter disease, megalencephalic 
leukoencephalopathy with subcortical cysts, and 
adrenoleukodystrophy, deserve mention here for 
the importance of MRI in achieving a  diagnosis.5 
In this context, van der Knapp et al. identified seven 
unrelated patients with extensive extra pyramidal 
movement abnormalities, ataxia, and spasticity.2 
An MRI brain scan revealed atrophied cerebral 
white matter, neostriatum, and cerebellum. 
Detailed metabolic work-ups were normal and 
none of the 7 had any history of perinatal insults. 
Magnetic resonance spectroscopy (MRS) showed 
elevated myo-inositol in the white matter, which 
is an indicator of gliosis. N-acetyl aspartate and 
choline levels were normal, suggesting that neither 
axonal loss nor active demyelination had occurred. 
They named this a distinctive leukoencephalopathy 
“hypomyelination with atrophy of the basal ganglia 
and cerebellum” (H-ABC) to indicate patients 
sharing these unique clinical and MR imaging features.2 
Our patient shared some of the above clinical and radiological features of H-ABC, and we present this case 
to emphasise the role of neuro-imaging in the diagnosis of this recent and rare nosological entity. Levodopa 
and cabiodopa were found to be effective in one patient with a similar condition.3 Unfortunately, our patient 
did not improve much during this treatment, although the dystonic spasms were initially alleviated.
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Figure 1: A magnetic resonance imaging brain scan revealing 
severe cortical atrophy with hypomyelination and atrophy 
of the caudate and putamen nuclei as well as the cerebellum.
